Semnur Pharmaceuticals, Inc. SEC filings SMNRW
Semnur Pharmaceuticals, Inc. has 221 filings in SEC EDGAR's recent list, going back to Mar 1, 2022. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jul 7, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 424B3 | Prospectus | Jul 7, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 7, 2026 | Jul 3, 2026 |
| 424B3 | Prospectus | Jul 1, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2026 | Jun 25, 2026 |
| 424B3 | Prospectus | Jun 15, 2026 | — |
| 424B3 | Prospectus | Jun 15, 2026 | — |
| EFFECT | Filing | May 18, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| POS AM | Filing | May 12, 2026 | — |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Agreement ended
|
Apr 23, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 17, 2026 | Mar 13, 2026 |
| 10-K | Annual report | Feb 27, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Dec 29, 2025 | — |
| 424B3 | Prospectus | Dec 29, 2025 | — |
| CORRESP | Letter to the SEC | Dec 23, 2025 | — |
| S-1/A | Amended registration statement | Dec 19, 2025 | — |
| S-8 | Employee stock plan registration | Dec 3, 2025 | — |
| S-8 | Employee stock plan registration | Dec 3, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 3, 2025 | Dec 3, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| S-1 | Registration statement | Oct 21, 2025 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Sep 26, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 4, 2025 | Sep 3, 2025 |
| DEFA14A | Additional proxy material | Aug 22, 2025 | — |
| 425 | Current report | Aug 22, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 22, 2025 | Aug 20, 2025 |
| 10-Q | Quarterly report | Aug 15, 2025 | Jun 30, 2025 |
| NT 10-Q | Notification of late filing | Aug 14, 2025 | Jun 30, 2025 |
| 424B3 | Prospectus | Aug 13, 2025 | — |
| EFFECT | Filing | Aug 12, 2025 | — |
| S-4/A | Filing | Aug 12, 2025 | — |
| CORRESP | Letter to the SEC | Aug 11, 2025 | — |
| 425 | Current report | Aug 11, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 11, 2025 | Aug 11, 2025 |
| S-4/A | Filing | Aug 11, 2025 | — |
| CORRESP | Letter to the SEC | Aug 8, 2025 | — |
| S-4/A | Filing | Aug 8, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 7, 2025 | — |
| 425 | Current report | Jul 28, 2025 | — |
| 8-K |
Current report
Material agreement
|
Jul 28, 2025 | Jul 22, 2025 |
| CORRESP | Letter to the SEC | Jul 23, 2025 | — |
| S-4/A | Filing | Jul 23, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2025 | — |
| 25-NSE | Delisting notice | Jul 14, 2025 | — |
| 425 | Filing | Jul 11, 2025 | — |
| 8-K |
Current report
Other events
|
Jul 11, 2025 | Jul 11, 2025 |
| CORRESP | Letter to the SEC | Jul 2, 2025 | — |
| S-4/A | Filing | Jul 2, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2025 | — |
| 8-K |
Current report
Other events
|
Jun 12, 2025 | Jun 11, 2025 |
| CORRESP | Letter to the SEC | Jun 11, 2025 | — |
| S-4/A | Filing | Jun 11, 2025 | — |
| UPLOAD | Letter from the SEC | May 20, 2025 | — |
| 10-Q | Quarterly report | May 16, 2025 | Mar 31, 2025 |
| NT 10-Q | Notification of late filing | May 15, 2025 | Mar 31, 2025 |
| 425 | Current report | May 12, 2025 | — |
| 8-K |
Current report
Other events
|
May 12, 2025 | May 9, 2025 |
| 8-K |
Current report
Material agreement
|
Apr 22, 2025 | Apr 16, 2025 |
| CORRESP | Letter to the SEC | Apr 21, 2025 | — |
| S-4/A | Filing | Apr 21, 2025 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Apr 16, 2025 | Apr 11, 2025 |
| 425 | Current report | Apr 9, 2025 | — |
| 8-K |
Current report
Listing notice
|
Apr 9, 2025 | Apr 2, 2025 |
| 10-K | Annual report | Apr 2, 2025 | Dec 31, 2024 |
| NT 10-K | Notification of late filing | Apr 1, 2025 | Dec 31, 2023 |
| UPLOAD | Letter from the SEC | Mar 28, 2025 | — |
| DEF 14A | Proxy statement | Mar 27, 2025 | Apr 10, 2025 |
| CORRESP | Letter to the SEC | Mar 25, 2025 | — |
| PRER14A | Proxy statement | Mar 25, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 25, 2025 | — |
| PRE 14A | Preliminary proxy statement | Mar 20, 2025 | Mar 20, 2025 |
| 425 | Current report | Mar 12, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 12, 2025 | Mar 11, 2025 |
| 425 | Form 8-k | Feb 11, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 11, 2025 | Feb 11, 2025 |
| 425 | Form 8-k | Jan 8, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 8, 2025 | Jan 8, 2025 |
| UPLOAD | Letter from the SEC | Dec 12, 2024 | — |
| 425 | Current report | Dec 11, 2024 | — |
| 8-K |
Current report
Other events
|
Dec 11, 2024 | Dec 11, 2024 |
| 10-Q | Quarterly report | Nov 19, 2024 | Sep 30, 2024 |
| NT 10-Q | Notification of late filing | Nov 14, 2024 | Sep 30, 2024 |
| 425 | Current report | Nov 12, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 12, 2024 | Nov 11, 2024 |
| S-4 | Registration for a merger or exchange | Nov 6, 2024 | — |
| 425 | Filing | Oct 11, 2024 | — |
| 8-K |
Current report
Other events
|
Oct 11, 2024 | Oct 11, 2024 |
| 425 | Filing | Oct 7, 2024 | — |
| 8-K |
Current report
Listing notice
|
Oct 7, 2024 | Oct 2, 2024 |
| 425 | Current report | Sep 12, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 12, 2024 | Sep 11, 2024 |
| 425 | Current report | Sep 5, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 5, 2024 | Aug 30, 2024 |
| 10-Q | Quarterly report | Aug 19, 2024 | Jun 30, 2024 |
| NT 10-Q | Filing | Aug 14, 2024 | Jun 30, 2024 |
| 425 | Current report | Aug 9, 2024 | — |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Aug 9, 2024 | Aug 9, 2024 |
| 8-K |
Current report
Auditor change
|
Jul 17, 2024 | Jul 15, 2024 |
| 425 | Current report | Jul 10, 2024 | — |
| 8-K |
Current report
Material agreement, New debt, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Jul 10, 2024 | Jul 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 5, 2024 | Jul 2, 2024 |
| DEF 14A | Proxy statement | Jun 28, 2024 | Jul 10, 2024 |
| 8-K |
Current report
Agreement ended, Regulation FD disclosure
|
Jun 27, 2024 | Jun 26, 2024 |
| PRE 14A | Preliminary proxy statement | Jun 18, 2024 | Jun 18, 2024 |
| 10-Q | Quarterly report | May 22, 2024 | Mar 31, 2024 |
| NT 10-Q | Notification of late filing | May 15, 2024 | Mar 31, 2024 |
| 10-K | Annual report | Apr 1, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Listing notice
|
Feb 27, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jan 10, 2024 | Jan 9, 2024 |
| 425 | Form 425 | Dec 29, 2023 | — |
| DEFA14A | Additional proxy material | Dec 29, 2023 | — |
| 425 | Current report | Dec 29, 2023 | — |
| 8-K |
Current report
Other events
|
Dec 29, 2023 | Dec 29, 2023 |
| DEFM14A | Filing | Dec 15, 2023 | — |
| 425 | Current report | Nov 20, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Nov 20, 2023 | Nov 17, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 425 | Current report | Oct 11, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
|
Oct 11, 2023 | Oct 11, 2023 |
| DEFR14A | Proxy statement | Sep 28, 2023 | — |
| DEF 14A | Proxy statement | Sep 25, 2023 | Oct 11, 2023 |
| PRE 14A | Preliminary proxy statement | Sep 12, 2023 | Sep 11, 2023 |
| 425 | Form 425 | Aug 31, 2023 | — |
| 425 | Current report | Aug 30, 2023 | — |
| 8-K |
Current report
Other events
|
Aug 30, 2023 | Aug 29, 2023 |
| 425 | Current report | Aug 28, 2023 | — |
| 8-K |
Current report
Material agreement
|
Aug 28, 2023 | Aug 23, 2023 |
| 10-Q | Quarterly report | Aug 15, 2023 | Jun 30, 2023 |
| NT 10-Q | Notification of late filing | Aug 14, 2023 | Jun 30, 2023 |
| 425 | Current report | Aug 4, 2023 | — |
| 425 | Current report | Aug 4, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2023 | Aug 4, 2023 |
| 425 | Current report | Jul 13, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Jul 13, 2023 | Jul 13, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 425 | Form 425 | Apr 12, 2023 | — |
| 425 | Form 425 | Apr 12, 2023 | — |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Apr 12, 2023 | Apr 11, 2023 |
| 10-K | Annual report | Mar 17, 2023 | Dec 31, 2022 |
| 425 | Form 425 | Jan 26, 2023 | — |
| 8-K/A |
Amended current report
Material agreement, Regulation FD disclosure
|
Jan 26, 2023 | Jan 25, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 26, 2023 | Jan 25, 2023 |
| 10-Q | Quarterly report | Nov 16, 2022 | Sep 30, 2022 |
| NT 10-Q | Form nt 0-q | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Auditor change
|
Oct 19, 2022 | Oct 14, 2022 |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Other events
|
May 27, 2022 | May 26, 2022 |
| 10-Q | Quarterly report | May 23, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Other events
|
Apr 15, 2022 | Apr 11, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
|
Apr 12, 2022 | Apr 6, 2022 |
| 424B3 | Prospectus | Apr 7, 2022 | — |
| EFFECT | Filing | Apr 6, 2022 | — |
| CERT | Filing | Apr 6, 2022 | — |
| 8-A12B | Form 8a-12b | Apr 6, 2022 | — |
| S-1/A | Amended registration statement | Apr 5, 2022 | — |
| CORRESP | Letter to the SEC | Apr 4, 2022 | — |
| CORRESP | Letter to the SEC | Apr 4, 2022 | — |
| S-1/A | Amended registration statement | Mar 28, 2022 | — |
| S-1/A | Amended registration statement | Mar 22, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 10, 2022 | — |
| S-1 | Registration statement | Mar 1, 2022 | — |
Showing 165 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SMNR (OTC), SMNRW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1913577
- Former names
- Denali Capital Acquisition Corp. (until Sep 23, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.